December 9, 2021Webinar

Inclusion of the Mexican Pharmaceutical Industry in the United States of America

Senior Counsel Karl Nobert joins the Asociación Mexicana para la Distribución Institucional para la Salud A.C. (ASMEDIS) and Asens Consulting S.C., for a virtual presentation focusing on the legal requirements a pharmaceutical or medical devices company, specifically those based in Mexico, must meet to commercialize products in the United States.

Specifically, Karl will review the most common challenges foreign pharmaceutical and medical devices companies face in getting the approval of the Food and Drug Administration (FDA) and tips for developing a compliance model that is mindful of FDA regulations, and those of other organizations, to establish long-term business relationships with U.S. based customers.

Thursday, December 9, 2021


back to top